The Journal of
Clinical Psychiatry

Psychopharmacology Schizophrenia/Schizoaffective Disorders

Insights February 17, 2022

Emerging Treatments in Schizophrenia Video

Christoph U. Correll ; Oliver Howes ; Anissa Abi-Dargham

Experts discuss the brain circuits involved in schizophrenia, the current medications, and new agents in phase 3 trials that do not directly block postsynaptic D2 receptors. Phase 2 data on one of these agents, the TAAR1 agonist ulotaront, are summarized.

Read the InfoPack

Save

Cite

Sponsored

PsychCase360: Choosing the Right Long-Acting Injectable for Patients With Schizophrenia

Explore two real-world schizophrenia cases with Roueen Rafeyan, MD and Melissa Vitale, PMHNP as they discuss challenges with medication adherence, transitioning to long-acting injectables (LAIs), and personalizing treatment strategies to improve patient outcomes.

Vol 86 • 2025 • Number 2

Read the Current Issue

Original Research

Incidence and Risk Factors for Suicide Attempt During Pregnancy and Postpartum

Original Research

Valbenazine in Elderly Adults With Tardive Dyskinesia

Academic Highlights

Optimizing Treatment With Aripiprazole Monohydrate: Pharmacokinetic Advantages of Long-Acting Injectable Formulations, A Consensus Panel Report

Original Research

Older Adults Visiting Emergency Departments for Mental Health Issues:A CHIRPP Database Study

Consensus Statement

Developing a Treatment-Resistant Depression Consultation Program, Part I: Practical and Logistical Considerations

Brief Report

Psychosocial Correlates of Optimism among US Military Veterans

View current Issue

Related Articles

Cognitive Impairment, Reward Pathways and Treatment Challenges in Schizophrenia Video

Insights

Cognitive Impairment, Reward Pathways and Treatment Challenges in Schizophrenia Video

January 14, 2023

Evaluating different domains of negative symptoms separately to better understand their impact on functional outcomes, particularly cognitive symptoms, is important in the treatment of patients with schizophrenia, especially intervening...

Dawn I. Velligan , Sanjai Rao

Treating Schizophrenia: Side Effects and Adherence Video

Insights

Treating Schizophrenia: Side Effects and Adherence Video

January 14, 2023

One of the central gaps that can affect treatment adherence for individuals with schizophrenia is side effects. Adverse events can lead to substantial impacts across all aspects of daily...

Sanjai Rao

Sequencing Therapy in the Treatment of Schizophrenia Video

Insights

Sequencing Therapy in the Treatment of Schizophrenia Video

January 14, 2023

Balancing and optimizing safety and efficacy when treating patients with schizophrenia can be challenging. New approaches to treatment may impact symptoms more effectively and contribute to better adherence. Sequencing,...

Sanjai Rao